Skip to main content

Editorial Board

Senior Editor
Piero Lo Monaco, PhD, Springer Nature, Germany
New Content Item Piero joined BMC in late 2021. His background is in molecular and cell biology. He studied at the Scuola Normale Superiore di Pisa for three years and completed his bachelor degree in Biological Sciences at the University of Pisa. He moved to France for his master degree in Life Sciences at the École normale supérieure de Lyon, where he attended courses on developmental biology, epigenetics, system biology. He pursued a PhD in cancer biology at the Cancer Research Center of Lyon, focusing on ribosome biogenesis and proposing it as a new target for anti-cancer treatment.
After his PhD, he went on with a short post-doc, investigating cell responses to ribosome biogenesis inhibitors in breast cancer. Finally, he gained some experience as a freelance scientific editor before joining BMC. He is now based in the Berlin office and upholds the values of open access.

Assistant Editors
Vrushali Mule, MSc, BSc, Springer Nature, India
Darpan Pardeshi, MSc, BSc, Springer Nature, India

Manuscript Editors
Harshal Dhondge, PhD, MSc, BSc, Springer Nature, India
Nikhil Ghate, PhD, MSc, BSc, Springer Nature, India
Akshay Ravindra Joshi, PhD, MPhil, MSc, BSc, Springer Nature, India
Rajasree K P, PhD, MSc, BSc, Springer Nature, India
Raunaq Singh Nagi, PhD, MSc, BSc, Springer Nature, India
Noohi Nasim, PhD, Springer Nature, India
Vaishnavi Nimbalkar, MSc, Springer Nature, India
Pranitha Pandit, PhD, MPhil, MSc, BSc, Springer Nature, India
Priya Sharma, PhD, MSc, BSc, Springer Nature, India
Varsha Shetty, PhD, Springer Nature, India
Neha Tiwari, PhD, M.Tech, B.Tech, Springer Nature, India
Pratibha Verma, PhD, MSc, BSc, Springer Nature, India

Senior Editorial Board Members

Demosthenes Panagiotaakos, Dr. med., Harokopio University of Athens, Greece
New Content Item Demosthenes Panagiotakos is a Professor in Biostatistics, Medical Research Methodology and Epidemiology at the Harokopio University in Athens, Greece, and a Member of the Scientific Committee on Health and Emerging Risks of the European Commission. Panagiotakos obtained his PhD in Biostatistics & Epidemiology from the University of Athens Medical School, Greece, and performed post-doctoral training at VAMC/Georgetown University, Washington DC, USA. His research interests include chronic disease epidemiology, public health, statistical modelling, forecasting, statistical machine learning, and application of multivariate statistical methods to medical sciences. He is currently a Senior Editorial Board member for BMC Medical Research Methodology.

Livia Puljak, MD, PhD, Catholic University of Croatia in Zagreb, Croatia
New Content ItemLivia Puljak is a full professor at the Catholic University of Croatia, where she is also the Head of the Center for evidence-based medicine and healthcare. She was trained in the United States, Italy and Canada. Her research interests include research methodology, evidence-based medicine and clinical epidemiology. She has published more than 200 articles in international peer-reviewed journals and mentored more than 60 defended diploma, Master and PhD theses. She was the inaugural director of Cochrane Croatia. In 2017, she was awarded the Chris Silagy Prize from Cochrane for her contribution to developing evidence-based medicine and in 2019, the Bill Silverman Prize for a research article containing the best criticism of Cochrane. She was listed among 2% of researchers with the highest citation impact in the world in the years 2020 and 2021.

Leonardo Roever, PhD, MBA, Federal University of Uberlândia, Brazil

New Content Item Dr. Roever is a Visiting Professor at the Graduate Program in Medicine and Health at the Faculty of Medicine of Bahia, Federal University of Bahia. CEO of Brazilian Network of Research in Meta-analysis (BRAMETIS).

The total of publications comprises more than 290 articles in journals specialized as an author and/or co-authored, including high-impact journals such as The Lancet, Nature, Nature Medicine, The Lancet Neurology, The Lancet Diabetes & Endocrinology, The Lancet Respiratory Medicine, The Lancet Global Health, European Heart Journal, JACC, Circulation and British Medical Journal (BMJ). Ad Hoc for the Medical Research Council (MRC) is part of UK Research and Innovation, Patient-Centered Outcomes Research Institute (PCORI-USA) and Health and Medical Research Fund (HMRF) - Hong Kong.

Senior Board Member - BMC Medical Research Methodology, Editorial Board (Neurology, International Journal of Cardiology, BMC Medical Research Methodology, BMC Emergency Medicine and Lipids in Health and Disease), Associated Editor [BMC Cardiovascular Disorders (Epidemiology) and Frontiers in Cardiovascular Medicine] , Academic Editor [Medicine (USA - Baltimore, Maryland)/ BioMed Research International (Critical Care)] and others.

Victor Volovici, MD, PhD, Erasmus MC University Medical Center Rotterdam, Netherlands
New Content Item Dr Victor Volovici obtained his PhD in neurosurgery and epidemiology (medical decision science) at the Erasmus University of Rotterdam (The Netherlands).  His research focuses on stroke, particularly hemorrhagic stroke (cerebral aneurysms, brain AVMs), and on applying new methodological techniques for causal inference to answer critical research questions arising during clinical practice. While being a firm supporter of the power of randomized controlled trials, in some cases (diseases with low prevalence, or heterogeneity of treatment definitions- e.g. surgical treatment) observational techniques should be employed to inform best practice. He aims to bring advanced statistical techniques closer to clinicians and make them more understandable and feasible to use. He further enjoys a partnership and a collaboration with the "Iuliu Hatieganu" University, Cluj-Napoca, Romania, where he served as a visiting professor of experimental microsurgery, participating and leading microsurgical skill acquisition and skill maintenance research.

Chang Xu, PhD, Anhui Medical University, China
Chang Xu picChang Xu is a full professor in Anhui Medical University since 2022. He received his MD and PhD in Chinese Evidence-based Medicine Centre from West China Hospital of Sichuan University. Since his PhD program, Dr. Xu saved his energy on creative ideas of evidence synthesis methods, clinical epidemiology, rapid evidence-based decision-making, and replicability & reproducibility of clinical trials, with a special focus on the methods for post-marketing drug safety assessment. He has published more than 30 academic papers in high-quality international journals such as BMJ, BMC Medicine, Sleep Medicine Reviews, Journal of Clinical Epidemiology, Research Synthesis Methods. In 2023, he was named in the Standford World's Top 2% Scientists list. His work has been supported by six national or institutional funding bodies.

Editorial Board Members
Fares Alahdab, MD, MSc, Houston Methodist Academic Institute & Weill Cornell Medical College, USA
Zakariya Algamal, PhD, University of Mosul, Iraq
Vance Berger, BS, MS, PhD, National Cancer Institute, USA
Sonu Menachem Maimonides Bhaskar, Liverpool Hospital, NSW Brain Clot Bank and Ingham Institute for Applied Medical Research, Australia
Cauane Blumenberg, PhD, International Center for Equity in Health, Federal University of Pelotas, Brazil
Christian Brettschneider, PD, Dr. rer. biol. hum., University Medical Center Hamburg-Eppendorf, Germany
Igor Burstyn, PhD, Drexel University, USA
Adam C Carle, PhD, Cincinnati Children's Hospital Medical Center, USA
Ferrán Catalá-López, PhD, National School of Public Health, ISCIII
Steve Coad, DPhil, Queen Mary University of London, UK
Bruno da Costa, PhD, University of Toronto, Canada
Rishi Desai, Brigham and Women's Hospital/Harvard Medical School, USA
Svjetlana Došenović, MD, PHD, University Hospital Center Split, Croatia
Anne Eaton, PhD, University of Minnesota, USA
Ahmed Elhakeem, PhD, University of Bristol, UK
Mohamed Estai, PhD, The University of Western Australia, Australia
Cindy Feng, PhD, Dalhousie University, Canada
Blanca Gallego Luxan, PhD, University of New South Wales, Australia
Gaetano Gallo, MD, PhD, University of Catanzaro, Italy
Gowri Gopalakrishna, Universiteit Maastricht, Netherlands
Yitka Graham, University of Sunderland, UK
Michael Grayling, PhD, Newcastle University, UK
Alden L Gross, PhD, MHS, Johns Hopkins Bloomberg School of Public Health, USA
Hui Guo, PhD, University of Manchester, UK
Candyce Hamel, Ottawa Hospital Research Institute, Canada
Catherine Hayes, PhD, University of Sunderland, UK
Martijn W Heymans, VU University Medical Center (VUmc) Amsterdam, Netherlands
Leonard Ho, PhD, The University of Edinburgh, UK
Chengcheng Hu, PhD, University of Arizona Mel and Enid Zuckerman College of Public Health, USA
Leila Jahangiry, Tabriz University of Medical Sciences, Iran
Zhehan Jiang, Peking University, China
Antonia Jelicic Kadic, University Hospital Split, Croatia
Ehsan Karim, PhD, The University of British Columbia, Canada
Paul H. Lee, PhD, University of Leicester, UK
Yisheng Li, PhD, University of Texas M.D. Anderson Cancer Center, USA
Jianchang Lin, PhD, Takeda Pharmaceuticals, USA
Ren Liu, PhD, University of California Merced, USA
Sheng Luo, The University of Texas Health Science Center at Houston, USA
Xianghua Luo, PhD, The University of Minnesota, USA
Chaochao Ma, MD, Peking Union Medical College Hospital, China
Mahdi Mahdizadeh, PhD, Hakim Sabzevari University, Iran
Tim Mathes, Dr. rer. medic., Institute for Medical Statistics, University Medical Center Göttingen, Germany
Tito R Mendoza, University of Texas MD Anderson Cancer Center, USA
Rahul Mhaskar, PhD, MPH, University of South Florida, USA
Seyyed Meysam Mousavi, Kerman University of Medical Sciences, Iran
Zachary Munn, PhD, University of Adelaide, Australia
Gustavo Nascimento, PhD, Duke-NUS Medical School, Singapore
Pentti Nieminen, PhD, University of Oulu, Finland
Anthony Nunes, University of Massachusetts Medical School, USA
Jung Hun Oh, PhD, Memorial Sloan Kettering Cancer Center, USA
Ivan Olier, PhD, Liverpool John Moores University, UK
Carel Peeters, VU University Medical Centre, Netherlands
Garrett Perchetti, MD, University of Washington School of Medicine, USA
Tina Poklepović Peričić, University of Split School of Medicine, Croatia
Fabian Prasser, Dr. rer. nat., Technical University of Munich, Germany
Jing Qian, PhD, University of Massachusetts Amherst, USA
Enrico Ripamonti, Karolinska Institutet, Sweden
José Antonio Roldán-Nofuentes, University of Granada, Spain
Agus Salim, PhD, La Trobe University, Australia
Rafael Sarkis-Onofre, PhD, Meridional Faculty (IMED), Brazil
Pei-Fang Su, PhD, National Cheng Kung University, Taiwan
Nicholas Syn, MD, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Wilson Tam, PhD, National University of Singapore, Singapore
Niansheng Tang, Dr. Sci. (Eng.), Yunnan University, China
Gian Luca Di Tanna, PhD, Dalle Molle Institute for Artificial Intelligence, Switzerland
Guglielmo Torre, Campus Bio-Medico University of Rome, Italy
Matt Vassar, PhD, Oklahoma State University Center for Health Sciences, USA
Swaroop Vedula, Johns Hopkins Whiting School of Engineering, USA
Ming Wang, PhD, Case Western Reserve University, USA
Xiaofeng Wang, PhD, Cleveland Clinic, USA
Jason Wasiak, PhD, MPH, Austin Clinical School, The Austin Hospital, USA
Penny Whiting, PhD, University of Bristol, UK
Martin Wolkewitz, Dr. sc. hum., IMBI, University Medical Center Freiburg
Chao Xu, PhD, The University of Oklahoma Health Sciences Center, USA
Hsin-Chou Yang, PhD, Academia Sinica, Taiwan
Ahtisham Younas, Ph.D., Memorial University of Newfoundland, Canada
Hadi Zamanian, Qom University of Medical Sciences, Iran
Yiqiang Zhan, PhD, Sun Yat-Sen University, China
Xuekui Zhang, PhD, University of Victoria, Canada
Yize Zhao, Weill Cornell Medicine, USA
Ahsan Zil-E-Ali, Pennsylvania State University, USA

Editorial Advisors
Luis Gabriel Cuervo, Pan American Health Organization, USA
Chiu-Hsieh (Paul) Hsu, University of Arizona, USA
Bradley Johnston, Texas A&M University, USA
Diane L. Lorenzetti, University of Calgary, Canada
Tom Trikalinos, Brown University, US

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    7.0 - 5-year Impact Factor
    2.055 - SNIP (Source Normalized Impact per Paper)
    1.778 - SJR (SCImago Journal Rank)

    2023 Speed
    40 days submission to first editorial decision for all manuscripts (Median)
    210 days submission to accept (Median)

    2023 Usage 
    3,126 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal